Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series.
Marcus MaurerMarkus MagerlEmel Aygören-PürsünKonrad BorkHenriette FarkasHilary LonghurstSorena Kiani-AlikhanLaurence BouilletIsabelle Boccon-GibodMauro CancianAndrea ZanichelliDavid LaunayPublished in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology (2022)
Healthcare teams need to undertake careful planning and monitoring after attenuated androgens discontinuation, and modify treatment strategies if HAE control is destabilized with an increased number of attacks. Discontinuation of attenuated androgens is definitively an option in an evolving HAE treatment landscape, and outcomes can be favourable with additional patient support and education.